| 1 |
34775854 | Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment. | 2022 Apr |
1 |
| 2 |
33030616 | Apatinib exhibits synergistic effect with pyrotinib and reverses acquired pyrotinib resistance in HER2-positive gastric cancer via stem cell factor/c-kit signaling and its downstream pathways. | 2021 Mar |
1 |
| 3 |
30864679 | [Corrigendum] Antiproliferative effects of imatinib mesylate on ZR‑75‑1 and MDA‑MB‑231 cell lines via PDGFR‑β, PDGF‑BB, c‑Kit and SCF expression. | 2019 May |
1 |
| 4 |
31138788 | A juxtacrine/paracrine loop between C-Kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancer. | 2019 May 28 |
1 |
| 5 |
29620139 | Antiproliferative effects of imatinib mesylate on ZR‑75‑1 and MDA‑MB‑231 cell lines via PDGFR‑β, PDGF‑BB, c‑Kit and SCF expression. | 2018 Jul |
1 |
| 6 |
30396237 | Inhibition of MicroRNA-221 and 222 Enhances Hematopoietic Differentiation from Human Pluripotent Stem Cells via c-KIT Upregulation. | 2018 Nov 30 |
1 |
| 7 |
28260860 | Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF genes. | 2017 |
3 |
| 8 |
25605011 | Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia. | 2015 Feb 20 |
2 |
| 9 |
25985771 | Predicting Effectiveness of Imatinib Mesylate in Tumors Expressing Platelet-Derived Growth Factors (PDGF-AA, PDGF-BB), Stem Cell Factor Ligands and Their Respective Receptors (PDGFR-α, PDGFR-β, and c-kit). | 2015 Sep |
4 |
| 10 |
26474484 | C-Kit Promotes Growth and Migration of Human Cardiac Progenitor Cells via the PI3K-AKT and MEK-ERK Pathways. | 2015 |
1 |
| 11 |
24333732 | Imatinib sensitizes endometrial cancer cells to cisplatin by targeting CD117-positive growth-competent cells. | 2014 Apr 1 |
1 |
| 12 |
24479586 | Inhibitory effects of imatinib mesylate on human epidermal melanocytes. | 2014 Mar |
2 |
| 13 |
24652072 | Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma. | 2014 Jun |
1 |
| 14 |
23278880 | Heterogeneity in the responses of human lung mast cells to stem cell factor. | 2013 Jan |
1 |
| 15 |
23420128 | Expression of stem cell factor in gastrointestinal stromal tumors: Implications for proliferation and imatinib resistance. | 2013 Feb |
5 |
| 16 |
23637779 | Tyrosine kinase inhibitors induce down-regulation of c-Kit by targeting the ATP pocket. | 2013 |
2 |
| 17 |
23749045 | Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cells. | 2013 Jun 7 |
1 |
| 18 |
22314612 | Regulation of cell proliferation through a KIT-mediated mechanism in benign prostatic hyperplasia. | 2012 Oct 1 |
1 |
| 19 |
20846303 | The role of stem cell factor and c-KIT in keloid pathogenesis: do tyrosine kinase inhibitors have a potential therapeutic role? | 2011 Feb |
1 |
| 20 |
19703239 | Development of lichen sclerosus et atrophicus while receiving a therapeutic dose of imatinib mesylate for chronic myelogenous leukemia. | 2010 Aug |
1 |
| 21 |
19956885 | Imatinib mesylate (STI571) enhances amrubicin-induced cytotoxic activity through inhibition of the phosphatidylinositol 3-kinase/Akt pathway in small cell lung cancer cells. | 2010 Jan |
2 |
| 22 |
20305142 | Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex. | 2010 Aug |
1 |
| 23 |
19118061 | Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate. | 2009 Jan 1 |
1 |
| 24 |
16521182 | STI571 (Glivec) suppresses the expression of vascular endothelial growth factor in the gastrointestinal stromal tumor cell line, GIST-T1. | 2006 Feb 7 |
1 |
| 25 |
16818499 | Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1alpha activity and vascular endothelial growth factor expression in small cell lung cancer cells. | 2006 Jun |
1 |
| 26 |
16823786 | PKC and cAMP positively modulate alkaline-induced exocytosis in the human mast cell line HMC-1. | 2006 Dec 15 |
1 |
| 27 |
16964380 | KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes. | 2006 Oct |
1 |
| 28 |
17044945 | The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells. | 2006 Oct 18 |
5 |
| 29 |
27265480 | The effect of imatinib mesylate on the erythroid colony formation from patients with polycythemia vera in the presence of different cytokines. | 2006 Sep 5 |
2 |
| 30 |
15637141 | Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib. | 2005 Apr 15 |
2 |
| 31 |
15800027 | Synergistic effect of SCF and TNF-alpha on the up-regulation of cell-surface expression of ICAM-1 on human leukemic mast cell line (HMC)-1 cells. | 2005 Jul |
1 |
| 32 |
16210056 | Stem cell factor stimulates the chemotaxis, integrin upregulation, and survival of human basophils. | 2005 Oct |
2 |
| 33 |
14985355 | Stem cell factor/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells. | 2004 Apr 30 |
1 |
| 34 |
15070666 | Serum KIT and KIT ligand levels in patients with gastrointestinal stromal tumors treated with imatinib. | 2004 Apr 15 |
6 |
| 35 |
15141010 | The insulin-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742, in combination with STI571, delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling. | 2004 May |
1 |
| 36 |
15322333 | Stem cell factor and H2O2 induce GLUT1 translocation in M07e cells. | 2004 |
1 |
| 37 |
15511212 | Modulation of c-Kit/SCF pathway leads to alterations in topoisomerase-I activity in small cell lung cancer. | 2004 |
1 |
| 38 |
12475982 | The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases. | 2003 Feb 14 |
1 |
| 39 |
12616857 | [Preclinical and clinical profile of imatinib mesilate, a potent protein-tyrosine kinase inhibitor for CML therapy]. | 2003 Feb |
4 |
| 40 |
12800187 | c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571. | 2003 Aug 20 |
1 |
| 41 |
12901973 | Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit. | 2003 Aug |
2 |
| 42 |
12960256 | STI571 inhibits growth and adhesion of human mast cells in culture. | 2003 Dec |
1 |
| 43 |
14635084 | Imatinib mesylate causes hypopigmentation in the skin. | 2003 Dec 1 |
2 |
| 44 |
12134042 | Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells. | 2002 Aug |
1 |
| 45 |
11751479 | Effects of signal transduction inhibitor 571 in acute myelogenous leukemia cells. | 2001 Dec |
1 |
| 46 |
12578590 | [Low Concentrations of STI571 Enhances beta1 Integrin Mediated Inhibitory Effect on Proliferation of Myeloid Progenitors in Ph(+)Chronic Myeloid Leukemia] | 2001 Sep |
1 |
| 47 |
10955819 | The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth. | 2000 Aug |
3 |
| 48 |
10991971 | Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. | 2000 Oct |
2 |